ChemLifeIntel
Access

Antiseptic Wipes

TRACKED

CASHSN
THERAPEUTIC AREAS
MOLECULE INTELLIGENCE SNAPSHOTlive
14
Manufacturers monitored
38
Intelligence briefs
3
Active regulatory actions
₹2,800 Cr
Est. India export value

INTELLIGENCE

Showing 3 of 3 briefs for Antiseptic Wipes
REGULATORY INTELLIGENCE·Recall

Laboratorios Jaloma Recalls 211,875 Hand Sanitizer Bottles Over cGMP Deviations: Supply Chain Implications

Laboratorios Jaloma S.A. de C.V. initiated a Class II recall of 211,875 bottles of Jaloma Antiseptic Hand Sanitizer due to cGMP deviations at its Guadalajara, Mexico facility. This event, terminated in August 2022, underscores persistent quality control challenges for OTC drug manufacturers. Procurement and regulatory teams must scrutinize supplier cGMP compliance, especially for critical products like sanitizers, to mitigate supply chain disruptions and ensure product integrity for end-users.

90-Day Activity
CMCatherine Morrow· Senior Regulatory Intelligence Analyst
57 min ago
REGULATORY INTELLIGENCE·Recall

Broncolin's HERBACIL Hand Sanitizer Class I Recall: Methanol Contamination Exposes Supply Chain Risks

Broncolin, S.A. de C.V. faced a Class I recall for its HERBACIL Hand Sanitizer due to methanol contamination and subpotent ethanol. This event, impacting 26,972 bottles distributed nationwide in the USA, highlights critical supply chain vulnerabilities and the imperative for rigorous quality control. Procurement and regulatory teams must prioritize supplier vetting and robust testing to mitigate severe public health and commercial risks.

90-Day Activity
MKMeera Krishnan· Senior Regulatory Intelligence Analyst
57 min ago Recall
REGULATORY INTELLIGENCE·Warning Letter

GRUPO YACANA MEXICO Recall: cGMP Deviations Prompted Class II Action on Yacana Alcohol Antiseptic

GRUPO YACANA MEXICO SAS DE CV faced a Class II recall (D-1590-2020) for its Yacana Alcohol Antiseptic 70% Topical Solution due to cGMP deviations. This action, initiated on August 18, 2020, involved 55,560 bottles distributed to Texas. The recall's termination on May 17, 2023, indicates remediation, but highlights persistent quality control risks in cross-border OTC pharmaceutical supply chains for procurement and regulatory teams.

90-Day Activity
MKMeera Krishnan· Senior Regulatory Intelligence Analyst
1h ago